Effect of Tuvarak taila cream in the management of sidhma kushtha (Pityriasis versicolor)

A COMPARATIVE CLINICAL STUDY ON TUVARAK TAILA CREAM AND 2 PERCENT TOPICAL KETOCONAZOLE IN THE MANAGEMENT OF SIDHMA KUSHTHA (PITYRIASIS VERSICOLOR) IN CHILDREN- AN OPEN LABELLED RANDOMIZED CONTROLLED CLINICAL TRIAL - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/10/074823

Enrollment

Registered

2024-10-07

Start date

Unknown

Completion date

Unknown

Last updated

2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients between 10 to 16 years of age irrespective of gender. 2.Patients with clinical signs of the disease Sidhma Kushtha (Pityriasis Versicolor)- Rajoghrishtma vimunchyati (Furferaceous scales) Tamra Varna (Reddish black,brown coloured macules) AlabupushpaVarna(Hypopigmentedmacules/hyperpigmented macules) Kandu (Itching) Urdhav kaye especially Uras (chest, trunk or neck) Tanu (thin plaques) 3. Patients found positive for KOH test 4. Willing to give assent/consent for the trial

Exclusion criteria

Exclusion criteria: 1.Children with congenital anomalies, chronic ailments such as tuberculosis, malignancy, cardiac, and renal disorders, autoimmune disorder or any other systemic illness 2.Patient have received systemic antifungal therapy within 1 month or topical antifungal therapy within 1 week of the commensal of study. 3.Patients with vitiligo, leprosy, pityriasis rosea, psoriasis, pityriasis alba, tinea capitis, tinea cruris any other skin disease 4.Parents of the patient not willing to participate in the trial

Design outcomes

Primary

Measure	Time frame
1 Antifungal effect of Tuvarak taila cream by performing KOH test. 2 Efficacy of Tuvarak taila cream in management of clinical features of Sidhma kushtha (pityriasis versicolor). Timeframe On 14th day/21st day (AT)and 42nd /49th day (FU). (Expected 90% improvement) and improvement in clinical features of Sidhma kushtha as per classical texts of Ayurveda Timepoint: 1 Antifungal effect of Tuvarak taila cream by performing KOH test. 2 Efficacy of Tuvarak taila cream in management of clinical features of Sidhma kushtha (pityriasis versicolor). i.e. Timeframe On 14th day/21st day (AT)and 42nd /49th day (FU). (Expected 90% improvement) and improvement in clinical features of Sidhma kushtha as per classical texts of Ayurveda	—

Measure

Time frame

1 Antifungal effect of Tuvarak taila cream by performing KOH test. 2 Efficacy of Tuvarak taila cream in management of clinical features of Sidhma kushtha (pityriasis versicolor). Timeframe On 14th day/21st day (AT)and 42nd /49th day (FU). (Expected 90% improvement) and improvement in clinical features of Sidhma kushtha as per classical texts of Ayurveda Timepoint: 1 Antifungal effect of Tuvarak taila cream by performing KOH test. 2 Efficacy of Tuvarak taila cream in management of clinical features of Sidhma kushtha (pityriasis versicolor). i.e. Timeframe On 14th day/21st day (AT)and 42nd /49th day (FU). (Expected 90% improvement) and improvement in clinical features of Sidhma kushtha as per classical texts of Ayurveda

—

Secondary

Measure	Time frame
1.Improvement in quality of life of the child as per Children’s Dermatological Life Quality Index (CDLQI) (Expected 90% improvement)Timepoint: AT (3weeks for group 1) & (2weeks for group 2) Follow Up After 4 weeks for both groups i.e.(7weeks for group 1) & (6weeks for group 2)	—

Countries

India

Contacts

Public ContactDr Akshita Thakur

ALL INDIA INSTITUTE OF AYURVEDA

Vedvyas61@gmail.com9907513436

Outcome results